Biovail settled OSC case over a bill-and-hold sale and misleading releases
Biovail Corporation · Specialty pharmaceuticals
The case in brief
Visible before detection
Checks that could have surfaced it, on hindsight
Third-party confirmation
Direct confirmation from the customer on the delivery date would test the bill-and-hold claim.
Can mislead when: Counterparties can collude or ignore requests. A non-response is logged as a gap, never as a pass.
Document authenticity / direct pull
Pulling the shipping and warehouse records would show the tablets had not left Biovail.
Can mislead when: The company can refuse consent, and a refusal is itself a flag. Some banks and co-op banks are not on AA yet.
Books edit log
The invoice cancellation and re-issue would show in the books edit log.
Can mislead when: Logs can be disabled at database level (auditors qualified this in year one) or tampered with on export. Kubr needs the company to cooperate.
Where Kubr services would have helped
Financial diligence
Offered in India- C5 Pulling the shipping and warehouse records would show the tablets had not left Biovail.
- C12 The invoice cancellation and re-issue would show in the books edit log.
Valuation context
Offered in India- Peer multiples and the exit-multiple bridge would have shown how much of the story relied on valuation holding.
IC note
Offered in India- C5 Pulling the shipping and warehouse records would show the tablets had not left Biovail.
Mapped from the checks each service runs. A hindsight reading of public records, not a promise that the failure would have been found.
Same pattern
A summary of public documents. It reports what the sources say. It is not Kubr's finding and not a statement of guilt.